Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles S. Berkman currently holds 111,042 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles S. Berkman has been a net seller of LGND stock. They have purchased $41.3K and sold $21.4M worth of shares.
Charles S. Berkman's most recent insider trade was on Apr 7, 2026, when they sold 13,542 shares at $0.00 per share.
Charles S. Berkman serves as Executive at LIGAND PHARMACEUTICALS INC (LGND). They have executed 174 insider transactions totaling $21.5M over their tenure at the company.
Charles S. Berkman holds the position of Executive at LIGAND PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Charles S. Berkman has shown a selling trading pattern, with $41.3K in total purchases and $21.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Charles S. Berkman was on Feb 4, 2021, when they sold $3.2M worth of LGND shares. This transaction involved 18,097 shares at $178.50 per share.
Charles S. Berkman currently owns 111,042 shares of LIGAND PHARMACEUTICALS INC (LGND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles S. Berkman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles S. Berkman has 174 Form 4 filings on record as an insider at LIGAND PHARMACEUTICALS INC.
Set alerts for Charles S. Berkman and 40,000+ other insiders.